Medly AI Raises $8M for AI Tutoring Platform Expansion

Medly AI, a UK-based educational technology firm, has successfully closed a $8 million seed funding round. The capital injection is earmarked for enhancing its artificial intelligence-driven exam preparation platform and broadening its reach into new student demographics and international territories. This significant seed investment underscores the growing investor confidence in AI's potential to revolutionize personalized learning.

The funding round was spearheaded by Felix Capital, a prominent venture capital firm known for its investments in consumer and technology sectors. The round also saw continued support from existing backers Eka Ventures and Ada Ventures, alongside strategic contributions from notable angel investors. These include Andrey Dobrynin, CEO of InvestEngine; Al Giles, Venture Partner at Creator Fund; Jean Hammond, General Partner at LearnLaunch Accelerator; and Hector Mason, General Partner at Episode 1 Ventures. The collective backing highlights a strong belief in Medly AI's innovative approach to academic support.

Founded by former UCL medical graduates Dr. Paul Jung and Dr. Kavi Samra, Medly AI is built on a sophisticated AI tutor designed to offer tailored academic assistance. The platform leverages a proprietary framework that integrates seven distinct large language models, augmented by principles from neuroscience and pedagogical research. This multi-faceted approach allows the AI to meticulously track student progress and learning behaviors, enabling it to deliver adaptive feedback and customized support, a critical differentiator in the competitive edtech market.

Medly AI's platform empowers students to engage with practice questions and receive immediate, actionable feedback. Crucially, the AI provides insights into how students can optimize their answers to achieve higher marks, particularly beneficial for subjects requiring detailed responses. The system also incorporates advanced features like handwriting recognition, facilitating a more natural interaction for students using tablets and styluses, especially in STEM subjects such as mathematics and chemistry. Since its launch in February 2025, the platform has already attracted over 400,000 users in the UK, with students dedicating approximately an hour daily to its features.

The edtech market is experiencing a significant shift towards personalized learning solutions, driven by the increasing demand for supplemental education. With nearly a third of 11-16 year olds in the UK receiving private tutoring, the cost and accessibility of such services remain a barrier for many. Medly AI aims to democratize personalized academic support, making adaptive tutoring accessible to a wider student population. "Our aim is to make personalized academic support more widely accessible by providing students with tutoring that adapts to how they learn," stated Dr. Paul Jung, co-founder and CEO of Medly AI. The company is actively researching the platform's impact on student attainment, with trials involving over 1,000 students underway.

Looking ahead, Medly AI is not only focused on deepening its capabilities within the UK market but also on aggressive international expansion. The company has already initiated its global strategy with the launch of SAT preparation modules in the United States, with plans to introduce support for AP and ACT exams by year-end. Further development includes proprietary models for specific educational functions like automated marking and advanced pedagogy, catering to students preparing for higher education and beyond standard exam requirements. This strategic growth plan, fueled by the new funding, positions Medly AI to become a significant player in the global AI-powered education sector.